High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial
about
Recent clinical trials in lupus nephritis.Association between low-dose pulsed intravenous cyclophosphamide therapy and amenorrhea in patients with systemic lupus erythematosus: a case-control study.Efficacy and safety data of belimumab in patients with systemic lupus erythematosus.High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseasesRepeated treatment with high dose cyclophosphamide for severe autoimmune diseasesTreatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance.High-dose chemotherapy and multiple sclerosis.Clearing the complexity: immune complexes and their treatment in lupus nephritis.Efficacy and safety of nonbiologic immunosuppressants in the treatment of nonrenal systemic lupus erythematosus: a systematic review.Intravenous cyclophosphamide and oral prednisolone is a safe and effective treatment option for idiopathic membranous nephropathy.High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies.Stem cell therapy: resetting autoimmunity or postponing the inevitable?Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus.Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravation.Long-term systemic lupus erythematosus disease control after allogeneic bone marrow transplantation.Regulatory T Cells As Potential Targets for HIV Cure Research.
P2860
Q33924437-E07EA403-7A6B-46EB-9798-7B60EED3D075Q33929673-0AF4AB6F-398B-4394-91E1-23F9777DAB3DQ34369628-F4FC3277-3C92-4B80-A9A4-67CBFEEF5995Q34986999-D650DEFA-8522-41C4-AA70-14EC04BEF527Q36562866-9C11AFBC-5F44-4850-96BC-74334043F542Q36730633-1DDDAB56-14C1-4BA5-BC4F-9A5A6D74ED12Q37822255-D05E4087-A3C2-46AC-8E80-639376159B08Q37892917-287A4397-A9CC-43AC-9951-761B9F7D0E71Q38101015-AE66BFE9-397C-46AB-A072-AC768179CC50Q38602846-A9826B98-22E3-47F5-9ADD-3F764689DA3AQ41814408-18D4A136-72EB-4509-BB76-932A277E3C36Q42224815-17114B2A-F990-47F5-B900-78F67C6FB9DCQ46374758-BC60DC79-D330-42C3-9ABE-8032FA250CD0Q47131684-D699618A-490B-4635-995A-01EFC172824AQ47962680-B062A3E2-0074-435E-B17C-0DC8394B73CCQ52715799-BDFF92C0-22B2-40D1-9E75-1DCF268FDEB8
P2860
High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
High-dose cyclophosphamide ver ...... a prospective randomized trial
@ast
High-dose cyclophosphamide ver ...... a prospective randomized trial
@en
High-dose cyclophosphamide ver ...... a prospective randomized trial
@nl
type
label
High-dose cyclophosphamide ver ...... a prospective randomized trial
@ast
High-dose cyclophosphamide ver ...... a prospective randomized trial
@en
High-dose cyclophosphamide ver ...... a prospective randomized trial
@nl
prefLabel
High-dose cyclophosphamide ver ...... a prospective randomized trial
@ast
High-dose cyclophosphamide ver ...... a prospective randomized trial
@en
High-dose cyclophosphamide ver ...... a prospective randomized trial
@nl
P2093
P2860
P356
P1476
High-dose cyclophosphamide ver ...... a prospective randomized trial
@en
P2093
Douglas Gladstone
Laurence S Magder
Michael Fillius
Richard J Jones
Robert A Brodsky
P2860
P304
P356
10.1002/ART.27371
P577
2010-05-01T00:00:00Z